Physician

Hematology

Robert Dillman is an expert in the field of Hematology. He studied medicine at Baylor College of Medicine. He over the years received 1 awards: "Super Doctor". Robert Dillman is a published doctor. He published 45 publications, including: 'High-Dose IL2 in Metastatic Melanoma: Better Survival in Patients Immunized with Antigens from Autologous Tumor Cell Lines.'

Publications

---

• High-Dose IL2 in Metastatic Melanoma: Better Survival in Patients Immunized with Antigens from Autologous Tumor Cell Lines.
• Cancer stem cell antigen-based vaccines: the preferred strategy for active specific immunotherapy of metastatic melanoma?
• Tumor Stem Cell Antigens as Consolidative Active Specific Immunotherapy: A Randomized Phase II Trial of Dendritic Cells Versus Tumor Cells in Patients With Metastatic ...
• Should high-dose interleukin-2 still be the preferred treatment for patients with metastatic melanoma?
• Defining the Critical Hurdles in Cancer Immunotherapy.
• Features associated with survival in metastatic melanoma patients treated with patient-specific dendritic cell vaccines.
• Should High-Dose Interleukin-2 Still be the Preferred Treatment for Patients with Metastatic Renal Cell Cancer?
• Characterization of Interferon-?-Treated Melanoma Tumor Cells for Use in Dendritic Cell-Based Immunotherapy.
• A retrospective study of induction chemotherapy with docetaxel, cisplatinum, and 5-fluorouracil followed by concurrent radiotherapy with cetuximab in locally advanced ...
• Overall survival benefit from postoperative radiation therapy for organ-confined, margin-positive prostate Cancer.
• Durable complete response of refractory, progressing metastatic melanoma after treatment with a patient-specific vaccine.
• Intralesional lymphokine-activated killer cells as adjuvant therapy for primary glioblastoma.
• Developing an effective lung Cancer program in a community hospital setting.
• Phase II trial of dendritic cells loaded with antigens from self-renewing, proliferating autologous tumor cells as patient-specific antitumor vaccines in patients with...
• Identification of 12 or more lymph nodes in resected colon Cancer specimens as an indicator of quality performance.
• Surgical resection and long-term survival for octogenarians who undergo surgery for non-small-cell lung Cancer.
• Monoclonal antibodies in Cancer therapy: 25 years of progress.
• Lack of elevation of serum S100B in patients with metastatic melanoma as a predictor of outcome after induction with an autologous vaccine of proliferating tumor cells...
• Monitoring response to treatment in melanoma patients: potential of a serum glycomic marker.
• Immunophenotyping of chronic lymphoid leukemias.
• Human allogeneic and murine xenogeneic dendritic cells are cytotoxic to human tumor cells via two distinct pathways.
• Patient-specific vaccines derived from autologous tumor cell lines as active specific immunotherapy: results of exploratory phase I/II trials in patients with metastat...
• Community-based phase II trial of pentostatin, cyclophosphamide, and rituximab (PCR) biochemotherapy in chronic lymphocytic leukemia and small lymphocytic lymphoma.
• Improving survival for patients with breast Cancer compared with intramural and extramural benchmarks.
• Phase II study of belagenpumatucel-L, a transforming growth factor beta-2 antisense gene-modified allogeneic tumor cell vaccine in non-small-cell lung Cancer.
• Patient-specific dendritic-cell vaccines for metastatic melanoma.
• Phase II trial of subcutaneous interferon followed by intravenous hybrid bolus/continuous infusion interleukin-2 in the treatment of renal cell carcinoma: final result...
• Cancer patient survival improvement is correlated with the opening of a community Cancer center: comparisons with intramural and extramural benchmarks.
• Cancer vaccine potency: is there a dose/response relationship for patient-specific vaccines and clinical outcomes?
• High-dose chemotherapy and autologous stem cell rescue for metastatic breast Cancer: superior survival for tandem compared with single transplants.
• International Society for Biological Therapy for Cancer: 20th anniversary.
• Establishment and characterization of a human primary prostate carcinoma cell line, HH870.
• Intracavitary placement of autologous lymphokine-activated killer (LAK) cells after resection of recurrent glioblastoma.
• Serum cytokines in metastatic melanoma patients treated with an autologous tumor vaccine.
• Treatment of human solid malignancies with autologous activated lymphocytes and cimetidine: a phase II trial of the Cancer biotherapy research group.
• Unique aspects of supportive care using monoclonal antibodies in Cancer treatment.
• Treatment of low-grade B-cell lymphoma with the monoclonal antibody rituximab.
• Does continuous-infusion interleukin-2 increase survival in metastatic melanoma?
• Radioimmunotherapy of relapsed or refractory low-grade, follicular, or transformed B-cell non-Hodgkin's lymphoma.
• Radiolabeled anti-CD20 monoclonal antibodies for the treatment of B-cell lymphoma.
• Radioimmunotherapy for non-Hodgkin's lymphoma with yttrium 90 ibritumomab tiuxetan.
• Phase II trial of subcutaneous interleukin-2, subcutaneous interferon-alpha, 5-fluorouracil and cis-retinoic acid in the treatment of renal cell carcinoma: final resul...
• Irradiated cells from autologous tumor cell lines as patient-specific vaccine therapy in 125 patients with metastatic Cancer: induction of delayed-type hypersensitivit...
• Successful treatment of transitional cell carcinoma of the urethra with chemotherapy.

Schools

---

• Baylor University

• Baylor Affil Hosps

• Ben Taub Genl Hospital

• UCSD

Conditions Treated

---

• Skin Cancer

Doctors Specialties

---

• Hematology
• Medical Oncology
• Oncology

Accepted Insurances

---

Awards

---

• Super Doctor

Education

---

• University of California San Diego
• Baylor College of Medicine

Hospital

---

• Hoag Memorial Hospital Presbyterian

Helpful Reviews

---

Give Anonymous Review

Similar Doctors

---

	Dr. Dilruba N. Haque, MD This Doctor is OpenDoctor Recommended.
	Dr. Neil M. Barth, MD This Doctor is OpenDoctor Recommended.
	Dr. Greg R. Angstreich, MD This Doctor is OpenDoctor Recommended.
	Dr. Warren H. Fong, MD This Doctor is OpenDoctor Recommended.
	Dr. Andreea Nanci, MD This Doctor is OpenDoctor Recommended.
	Dr. Khosrow Mahdavi, MD This Doctor is OpenDoctor Recommended.
	Dr. Ana M. Rojas, MD
	Dr. John S. Cupp, MD This Doctor is OpenDoctor Recommended.
	Dr. Monica P. Mosquera Caro, MD This Doctor is OpenDoctor Recommended.

---

Doctor Directory | TOS | twitter | FB | Angel | blog